A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs

Clinical trial NCT06228326 · RECRUITING

Trial details

NCT number: NCT06228326
Sponsor: Krystal Biotech, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Non-small Cell Lung Cancer Metastatic Solid Tumor, Adult Advanced Cancer Lung Cancer (NSCLC)

Start date: 2024-04-17
Primary completion: 2027-02-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.